Παρακολούθηση
Matthew Lee
Matthew Lee
Clinical Senior Lecturer, University of Glasgow
Η διεύθυνση ηλεκτρονικού ταχυδρομείου έχει επαληθευτεί στον τομέα glasgow.ac.uk - Αρχική σελίδα
Τίτλος
Παρατίθεται από
Παρατίθεται από
Έτος
Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials
N Sattar, MMY Lee, SL Kristensen, KRH Branch, S Del Prato, NS Khurmi, ...
The lancet Diabetes & endocrinology 9 (10), 653-662, 2021
9922021
Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF)
MMY Lee, KJM Brooksbank, K Wetherall, K Mangion, G Roditi, ...
Circulation 143 (6), 516-525, 2021
3902021
Adenosine: physiology, pharmacology, and clinical applications
J Layland, D Carrick, M Lee, K Oldroyd, C Berry
JACC: Cardiovascular Interventions 7 (6), 581-591, 2014
3352014
Reducing personal exposure to particulate air pollution improves cardiovascular health in patients with coronary heart disease
JP Langrish, X Li, S Wang, MMY Lee, GD Barnes, MR Miller, FR Cassee, ...
Environmental health perspectives 120 (3), 367-372, 2012
3352012
Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS–NSTEMI …
J Layland, KG Oldroyd, N Curzen, A Sood, K Balachandran, R Das, ...
European heart journal 36 (2), 100-111, 2015
3102015
Lung ultrasound in acute heart failure: prevalence of pulmonary congestion and short-and long-term outcomes
E Platz, RT Campbell, B Claggett, EF Lewis, JD Groarke, KF Docherty, ...
JACC: Heart Failure 7 (10), 849-858, 2019
1812019
Diabetic cardiomyopathy
MMY Lee, JJV McMurray, A Lorenzo-Almorós, SL Kristensen, N Sattar, ...
Heart 105 (4), 337-345, 2019
1252019
Prevalence of prediabetes and undiagnosed diabetes in patients with HFpEF and HFrEF and associated clinical outcomes
SL Kristensen, PS Jhund, MMY Lee, L Køber, SD Solomon, CB Granger, ...
Cardiovascular drugs and therapy 31, 545-549, 2017
982017
Statins in the prevention and treatment of heart failure: a review of the evidence
MMY Lee, N Sattar, JJV McMurray, CJ Packard
Current atherosclerosis reports 21, 1-8, 2019
922019
Aficamten for symptomatic obstructive hypertrophic cardiomyopathy
MS Maron, A Masri, ME Nassif, R Barriales-Villa, M Arad, N Cardim, ...
New England Journal of Medicine 390 (20), 1849-1861, 2024
842024
How couples who have undergone in vitro fertilization decide what to do with surplus frozen embryos
RD Nachtigall, K Mac Dougall, J Harrington, J Duff, M Lee, G Becker
Fertility and sterility 92 (6), 2094-2096, 2009
772009
What do patients want? Expectations and perceptions of IVF clinic information and support regarding frozen embryo disposition
RD Nachtigall, K Mac Dougall, M Lee, J Harrington, G Becker
Fertility and sterility 94 (6), 2069-2072, 2010
672010
Fractional flow reserve vs. angiography in guiding management to optimize outcomes in non-ST-segment elevation myocardial infarction: the British Heart Foundation FAMOUS–NSTEMI …
J Layland, KG Oldroyd, N Curzen, A Sood, K Balachandran, R Das, ...
European Heart Journal 36 (2), 100, 2014
652014
Effect of neprilysin inhibition on left ventricular remodeling in patients with asymptomatic left ventricular systolic dysfunction late after myocardial infarction
KF Docherty, RT Campbell, KJM Brooksbank, JG Dreisbach, P Forsyth, ...
Circulation 144 (3), 199-209, 2021
612021
Dapagliflozin vs. metolazone in heart failure resistant to loop diuretics
SE Yeoh, J Osmanska, MC Petrie, KJM Brooksbank, AL Clark, ...
European Heart Journal 44 (31), 2966-2977, 2023
582023
Meta-analyses of results from randomized outcome trials comparing cardiovascular effects of SGLT2is and GLP-1RAs in Asian versus white patients with and without type 2 diabetes
MMY Lee, N Ghouri, DK McGuire, MK Rutter, N Sattar
Diabetes Care 44 (5), 1236-1241, 2021
582021
How do SGLT2 (sodium-glucose cotransporter 2) inhibitors and GLP-1 (glucagon-like peptide-1) receptor agonists reduce cardiovascular outcomes? Completed and ongoing mechanistic …
MMY Lee, MC Petrie, JJV McMurray, N Sattar
Arteriosclerosis, thrombosis, and vascular biology 40 (3), 506-522, 2020
532020
Renin–angiotensin system blockers, risk of SARS-CoV-2 infection and outcomes from CoViD-19: systematic review and meta-analysis
MMY Lee, KF Docherty, N Sattar, N Mehta, A Kalra, AS Nowacki, ...
European Heart Journal-Cardiovascular Pharmacotherapy 8 (2), 165-178, 2022
472022
Heart failure with preserved ejection fraction: everything the clinician needs to know
P Campbell, FH Rutten, MMY Lee, NM Hawkins, MC Petrie
The Lancet 403 (10431), 1083-1092, 2024
442024
Cardiovascular and mortality outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a meta-analysis with the FREEDOM cardiovascular outcomes trial
MMY Lee, SL Kristensen, HC Gerstein, JJV McMurray, N Sattar
Diabetes & Metabolic Syndrome: Clinical Research & Reviews 16 (1), 102382, 2022
322022
Δεν είναι δυνατή η εκτέλεση της ενέργειας από το σύστημα αυτή τη στιγμή. Προσπαθήστε ξανά αργότερα.
Άρθρα 1–20